COMPARATIVE-STUDY ON INCLUSION-COMPOUNDS OF 4-BIPHENYLACETIC ACID WITH BETA-CYCLODEXTRIN, HYDROXYPROPYLATED-BETA-CYCLODEXTRINS, AND METHYLATED-BETA-CYCLODEXTRINS
Ca. Ventura et al., COMPARATIVE-STUDY ON INCLUSION-COMPOUNDS OF 4-BIPHENYLACETIC ACID WITH BETA-CYCLODEXTRIN, HYDROXYPROPYLATED-BETA-CYCLODEXTRINS, AND METHYLATED-BETA-CYCLODEXTRINS, Drug development and industrial pharmacy, 20(14), 1994, pp. 2245-2265
The inclusion behavior of Hydroxypropyl-beta-Cyclodextrin (HP-beta-Cyd
) and of methylated-beta-Cyclodextrins, heptakis-(2,6-di-O-methyl)-bet
a-Cyclodextrin (DM-beta-Cyd) and heptakis-(2,3,6-tri-O-methyl)beta-Cyc
lodextrin (TM-beta-Cyd), in solution and solid state was compared with
that of natural beta-Cyclodextrin (beta-Cyd) using an anti-inflammato
ry drug, 4-biphenylacetic acid (BPAA), as a guest molecule. The solubi
lity of BPAA with beta-Cyd and beta-Cyd derivatives in aqueous solutio
n were determined. Stability constants were calculated by phase solubi
lity method at various pH values and temperatures. The formation of in
clusion complexes with beta-Cyd and beta-Cyd derivatives in the solid
state were confirmed by infrared spectroscopy, differential scanning c
alorimetry and X-Ray diffractometry, and in the liquid phase by ultrav
iolet spectroscopy, circular dichroism and NMR studies. Dissolution ra
te and ''in vitro'' release of BPAA from complexes were examined. The
results obtained suggest that DM-beta-Cyd is more effective than other
beta-Cyclodextrins in improving the pharmaceutical properties of BPAA
.